|
Immunic Inc (NASDAQ: IMUX) |
|
*Market share is calculated based on total revenue.
Publicly Traded Peers of Immunic Inc
X4 Pharmaceuticals Inc Share Performance
0.00%
30 Days
|
X4 Pharmaceuticals Inc
Profile
X4 Pharmaceuticals Inc is a biopharmaceutical company focused on the research and development of innovative treatments for rare diseases, particularly those involving the immune system and rare genetic disorders. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials, and ultimately bringing these therapies to market to improve patient outcomes.
More about X4 Pharmaceuticals Inc's Market Share
|
Curevac N v Share Performance
+56.52%
This Year
|
Curevac N v
Profile
CureVac N.V. is a biopharmaceutical company focused on developing and manufacturing innovative mRNA-based therapeutics and vaccines. Their business model involves leveraging their proprietary technology platform to develop a diverse pipeline of potential mRNA-based products, from early-stage research to clinical trials. CureVac N.V. collaborates with partners and organizations to advance their product candidates, aiming to address unmet medical needs and improve patient outcomes.
More about Curevac N v 's Market Share
|
Equillium Inc Share Performance
0.00%
30 Days
|
Equillium Inc
Profile
Equillium Inc operates on a business model that focuses on developing and commercializing novel treatments for immune and inflammatory disorders by leveraging their expertise in immunology and translational science. They aim to address unmet medical needs through the discovery and development of therapies targeting specific immune pathways.
More about Equillium Inc 's Market Share
|
Sources: Immunic Inc and all companies mentioned above in this report
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com